118 related articles for article (PubMed ID: 21310040)
1. A method to study the effect of bronchodilators on smoke retention in COPD patients: study protocol for a randomized controlled trial.
van Dijk WD; Scheepers PT; Cremers R; Lenders JW; Klerx W; van Weel C; Schermer TR; Heijdra Y
Trials; 2011 Feb; 12():37. PubMed ID: 21310040
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial.
van Dijk WD; Heijdra Y; Lenders JW; Klerx W; Akkermans R; van der Pouw A; van Weel C; Scheepers PT; Schermer TR
Respir Med; 2013 Jan; 107(1):112-9. PubMed ID: 23069326
[TBL] [Abstract][Full Text] [Related]
3. Interaction in COPD experiment (ICE): a hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease.
van Dijk WD; Heijdra Y; Scheepers PT; Lenders JW; van Weel C; Schermer TR
Med Hypotheses; 2010 Feb; 74(2):277-80. PubMed ID: 19800175
[TBL] [Abstract][Full Text] [Related]
4. Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
Devereux G; Cotton S; Barnes P; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Fielding S; Gompertz S; Haughney J; Lee AJ; McCormack K; McPherson G; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Trials; 2015 Jun; 16():267. PubMed ID: 26058585
[TBL] [Abstract][Full Text] [Related]
5. Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study.
Chen YF; Cheng YC; Chou CH; Chen CY; Yu CJ
BMC Pulm Med; 2019 Dec; 19(1):233. PubMed ID: 31795986
[TBL] [Abstract][Full Text] [Related]
6. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
7. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.
Hohlfeld JM; Vogel-Claussen J; Biller H; Berliner D; Berschneider K; Tillmann HC; Hiltl S; Bauersachs J; Welte T
Lancet Respir Med; 2018 May; 6(5):368-378. PubMed ID: 29477448
[TBL] [Abstract][Full Text] [Related]
8. Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials.
Li C; Cheng W; Guo J; Guan W
Int J Chron Obstruct Pulmon Dis; 2019; 14():799-808. PubMed ID: 31114181
[No Abstract] [Full Text] [Related]
9. Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities.
Corrao S; Brunori G; Lupo U; Perticone F
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28794142
[TBL] [Abstract][Full Text] [Related]
10. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
11. Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator.
Singh D; Balaguer V; Astbury C; Wählby-Hamrén U; Jimenez E; Seoane B; Villarroel C; Lei A; Aggarwal A; Psallidas I
Respir Res; 2020 Sep; 21(Suppl 1):102. PubMed ID: 32907566
[TBL] [Abstract][Full Text] [Related]
12. Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.
Magnussen H; Watz H; Kirsten A; Decramer M; Dahl R; Calverley PM; Towse L; Finnigan H; Tetzlaff K; Disse B
Respir Med; 2014 Apr; 108(4):593-9. PubMed ID: 24477080
[TBL] [Abstract][Full Text] [Related]
13. Inhaled long-acting bronchodilators for COPD.
Med Lett Drugs Ther; 2017 Apr; 59(1518):e64-e65. PubMed ID: 28377552
[No Abstract] [Full Text] [Related]
14. Inhaled short-acting bronchodilators for COPD.
Med Lett Drugs Ther; 2017 Apr; 59(1518):e62-e63. PubMed ID: 28377551
[No Abstract] [Full Text] [Related]
15. Impact of baseline COPD symptom severity on the benefit from dual
Vogelmeier CF; Kerwin EM; Bjermer LH; Tombs L; Jones PW; Boucot IH; Naya IP; Lipson DA; Compton C; Barnes N; Maltais F
Ther Adv Respir Dis; 2020; 14():1753466620968500. PubMed ID: 33167780
[TBL] [Abstract][Full Text] [Related]
16. V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results.
Devillier P; Garrigue E; D'Auzers G; Monjotin N; Similowski T; Clerc T
Respir Res; 2015 Jun; 16(1):68. PubMed ID: 26050967
[TBL] [Abstract][Full Text] [Related]
17. The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD.
Dean J; Panainte C; Khan N; Singh D
Respir Res; 2020 Dec; 21(1):323. PubMed ID: 33298062
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.
Bhatt SP; Dransfield MT; Cockcroft JR; Wang-Jairaj J; Midwinter DA; Rubin DB; Scott-Wilson CA; Crim C
Int J Chron Obstruct Pulmon Dis; 2017; 12():351-365. PubMed ID: 28176907
[TBL] [Abstract][Full Text] [Related]
20. Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study.
Wang MT; Liou JT; Lin CW; Tsai CL; Wang YH; Hsu YJ; Lai JH
JAMA Intern Med; 2018 Feb; 178(2):229-238. PubMed ID: 29297057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
